Rep. Chris Collins (R-N.Y.) has an extremely exciting opportunity for you.

Collins is the largest shareholder in Innate Immunotherapeutics, a small Australian biotech company, and a member of the companys board. And hes been happily talking up the stock to his congressional colleagues, The Hill reported Thursday .

The old image of congressional corruption was a machine politician who funneled government spending to his allies back home. But Congress doesnt really do earmarks anymore, thanks to a 2010 reform.

Collins, an early and vocal supporter of President Donald Trump , represents the new face of lawmaker self-dealing: a rich man using the stature of his office to become richer, and telling colleagues to come along for the ride. If you get in early, youll make a big profit, he told colleagues, according to other six Republican members.

Collins told The Hill he never discussed Innate Immunotherapeutics with his colleagues. He did, however, admit to telling some constituents about the stock. Ive presented opportunities in Buffalo, he told the paper . Ive said, Heres an opportunity. Listen. Read. Study. Make a decision. Thats the only thing I ever did, and that was in Buffalo.

Collins office denies any wrongdoing. Congressman Collins has followed all ethics rules and laws when it comes to his investments, spokeswoman Sarah Minkel told HuffPost in a statement.

As he would about the success of his children, he has never been shy about talking about the work of Innate Immunotherapeutics, Minkel said. The statement went on to promote the potential of the companys drug treating multiple sclerosis, and to point out that without congressional funding, it might never have been developed.